Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

May Roundup: 11 Wage Rulings on Class, Collective Actions No Photo Available

Jon Steingart

The month of May brought plenty of rulings in cases with one or two workers trying to assert claims on behalf of others. Whether it's ... (more story)

Staffing Rule Suit, Mayo COVID Claims And An Oathless Expert No Photo Available

Gianna Ferrarin

Nursing home trade groups sue over "nightmare" staffing rule, former Mayo Clinic workers get another shot at claims they were illegall... (more story)

Alaska Opioid Suit Moves Forward In Early Loss For PBMs No Photo Available

Dan McKay

An Alaska federal judge is allowing public nuisance claims to move forward against Express Scripts as pharmacy benefit managers are in... (more story)